Cargando…

Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study

INTRODUCTION: Orchiopexy for congenital cryptorchid testes is recommended between ½ and 1 year of age to preserve testicular germ cell maturation. Early operation is not enough to preserve fertility in 22 and 36% of cases. Aim of this study was to set up a protocol for optional adjuvant hormonal the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorup, Jorgen, Clasen-Linde, Erik, Dong, Lihua, Hildorf, Simone, Kristensen, Stine Gry, Andersen, Claus Yding, Cortes, Dina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996032/
https://www.ncbi.nlm.nih.gov/pubmed/29922233
http://dx.doi.org/10.3389/fendo.2018.00299
_version_ 1783330740766769152
author Thorup, Jorgen
Clasen-Linde, Erik
Dong, Lihua
Hildorf, Simone
Kristensen, Stine Gry
Andersen, Claus Yding
Cortes, Dina
author_facet Thorup, Jorgen
Clasen-Linde, Erik
Dong, Lihua
Hildorf, Simone
Kristensen, Stine Gry
Andersen, Claus Yding
Cortes, Dina
author_sort Thorup, Jorgen
collection PubMed
description INTRODUCTION: Orchiopexy for congenital cryptorchid testes is recommended between ½ and 1 year of age to preserve testicular germ cell maturation. Early operation is not enough to preserve fertility in 22 and 36% of cases. Aim of this study was to set up a protocol for optional adjuvant hormonal therapy after orchiopexy and thereafter cryopreservation of testicular biopsies from infants with bilateral cryptorchidism and high infertility risk. MATERIALS AND METHODS: We included 17 boys with bilateral cryptorchidism, normal FSH, and impaired germ cell number per tubular transverse section (G/T) in testicular biopsies at orchiopexy, 7 months to 3½ years old. Postoperatively, optional adjuvant LHRH (kryptocur(®)) 0.2 mg/0.1 mL 2× every second day in 16 weeks were offered. Ten boys were applicable for age matching according to parent’s choice of treatment regime and G/T. Five of them had kryptocur(®), and five were controls. Repeat bilateral testicular biopsy evaluation and cryopreservation were offered to all boys 12 months after primary orchiopexy. For cryopreservation, tissue pieces were incubated with a cryoprotectant with a slow program freezing. RESULTS: Two out of five kryptorcur(®)-treated boys normalized both the average G/T and the number of adult dark spermatogonia (Ad-S). Another kryptocur(®)-treated boy with initial low G/T and no Ad-S increased the G/T and achieved normal number of Ad-S at time of cryopreservation. In the control group, two patients reached only normal lower range regarding the G/T and the number of Ad-S. None of boys with less than average 0.2 G/T improved significantly, whether they were kryptocur(®)-treated or not. CONCLUSION: Based on literature and the present results, we recommend adjuvant LHRH treatment to boys with cryptorchidism and insufficient genuine gonadotropin stimulation at time of surgery, as these patients have high infertility risk. Cryopreservation should be an option in case of treatment failure of adjuvant LHRH. However, to avoid repeat surgery with biopsy, some parents may choose biopsy for cryopreservation at time of the initial bilateral orchiopexy, well informed that the procedure may only be truly indicated in 22 and 36% of the cases.
format Online
Article
Text
id pubmed-5996032
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59960322018-06-19 Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study Thorup, Jorgen Clasen-Linde, Erik Dong, Lihua Hildorf, Simone Kristensen, Stine Gry Andersen, Claus Yding Cortes, Dina Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Orchiopexy for congenital cryptorchid testes is recommended between ½ and 1 year of age to preserve testicular germ cell maturation. Early operation is not enough to preserve fertility in 22 and 36% of cases. Aim of this study was to set up a protocol for optional adjuvant hormonal therapy after orchiopexy and thereafter cryopreservation of testicular biopsies from infants with bilateral cryptorchidism and high infertility risk. MATERIALS AND METHODS: We included 17 boys with bilateral cryptorchidism, normal FSH, and impaired germ cell number per tubular transverse section (G/T) in testicular biopsies at orchiopexy, 7 months to 3½ years old. Postoperatively, optional adjuvant LHRH (kryptocur(®)) 0.2 mg/0.1 mL 2× every second day in 16 weeks were offered. Ten boys were applicable for age matching according to parent’s choice of treatment regime and G/T. Five of them had kryptocur(®), and five were controls. Repeat bilateral testicular biopsy evaluation and cryopreservation were offered to all boys 12 months after primary orchiopexy. For cryopreservation, tissue pieces were incubated with a cryoprotectant with a slow program freezing. RESULTS: Two out of five kryptorcur(®)-treated boys normalized both the average G/T and the number of adult dark spermatogonia (Ad-S). Another kryptocur(®)-treated boy with initial low G/T and no Ad-S increased the G/T and achieved normal number of Ad-S at time of cryopreservation. In the control group, two patients reached only normal lower range regarding the G/T and the number of Ad-S. None of boys with less than average 0.2 G/T improved significantly, whether they were kryptocur(®)-treated or not. CONCLUSION: Based on literature and the present results, we recommend adjuvant LHRH treatment to boys with cryptorchidism and insufficient genuine gonadotropin stimulation at time of surgery, as these patients have high infertility risk. Cryopreservation should be an option in case of treatment failure of adjuvant LHRH. However, to avoid repeat surgery with biopsy, some parents may choose biopsy for cryopreservation at time of the initial bilateral orchiopexy, well informed that the procedure may only be truly indicated in 22 and 36% of the cases. Frontiers Media S.A. 2018-06-05 /pmc/articles/PMC5996032/ /pubmed/29922233 http://dx.doi.org/10.3389/fendo.2018.00299 Text en Copyright © 2018 Thorup, Clasen-Linde, Dong, Hildorf, Kristensen, Andersen and Cortes. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Thorup, Jorgen
Clasen-Linde, Erik
Dong, Lihua
Hildorf, Simone
Kristensen, Stine Gry
Andersen, Claus Yding
Cortes, Dina
Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
title Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
title_full Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
title_fullStr Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
title_full_unstemmed Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
title_short Selecting Infants With Cryptorchidism and High Risk of Infertility for Optional Adjuvant Hormonal Therapy and Cryopreservation of Germ Cells: Experience From a Pilot Study
title_sort selecting infants with cryptorchidism and high risk of infertility for optional adjuvant hormonal therapy and cryopreservation of germ cells: experience from a pilot study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996032/
https://www.ncbi.nlm.nih.gov/pubmed/29922233
http://dx.doi.org/10.3389/fendo.2018.00299
work_keys_str_mv AT thorupjorgen selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy
AT clasenlindeerik selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy
AT donglihua selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy
AT hildorfsimone selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy
AT kristensenstinegry selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy
AT andersenclausyding selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy
AT cortesdina selectinginfantswithcryptorchidismandhighriskofinfertilityforoptionaladjuvanthormonaltherapyandcryopreservationofgermcellsexperiencefromapilotstudy